AbbVie Inc (ABBV)
107.69
+0.99 +0.93%
NYSE
Mar 8, 11:19
USD
View All Key Stats
Key Stats
Income Statement | |
Revenue (TTM) | 45.80B |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (TTM) | 2.86 |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Net Income (TTM) | 4.616B |
Profitability | |
Gross Profit Margin (Quarterly) | 66.20% |
Profit Margin (Quarterly) | 0.26% |
Dividend | |
Dividend Yield (Forward) | Upgrade |
Dividend Yield | 4.49% |
Price and Valuation | |
Market Cap | 190.17B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
PS Ratio | 3.930 |
PE Ratio | 37.65 |
Price to Book Value | 14.54 |
Other | |
Beta (5Y) | Upgrade |
Debt to Equity Ratio | 6.581 |
Free Cash Flow (Quarterly) | 4.575B |
Return on Equity | Upgrade |
View All ABBV News
News
-
WireHeadlineTime (ET)
-
Yahoo03/07 15:28
-
Yahoo03/07 05:51
-
Yahoo03/06 01:04
-
Yahoo03/05 11:30
-
Yahoo03/05 08:17
-
Yahoo03/04 15:21
-
Yahoo03/04 11:00
-
Yahoo03/03 07:00
-
Yahoo03/02 11:18
-
Yahoo03/02 06:01
-
Yahoo03/02 04:41
-
Yahoo03/01 13:33
-
SA Breaking News03/01 07:40
-
Yahoo03/01 05:34
-
Yahoo02/26 10:06
-
MT Newswires02/25 09:35
-
SA Breaking News02/25 08:10
-
Yahoo02/25 08:08
-
PR Newswire02/25 08:00
-
SA Breaking News02/25 07:39
View All Events
Events
Date | Type | Description |
---|---|---|
04/30/2021 | Earnings | AbbVie Inc First Quarter Earnings Results for 2021 |
04/30/2021 | Misc | AbbVie Inc First Quarter Earnings Conference Call for 2021 |
04/14/2021 | Dividends | Amount: 1.30, Declared Date: Feb 18 2021, Pay Date: May 14 2021 |
02/03/2021 | Earnings | AbbVie Inc Fourth Quarter Earnings Result for 2020 |
02/03/2021 08:00 CST | Misc | AbbVie Inc Fourth Quarter Earnings Conference Call for 2020 |
01/14/2021 | Dividends | Amount: 1.30, Declared Date: Oct 30 2020, Pay Date: Feb 16 2021 |
10/30/2020 | Earnings | AbbVie Inc Third Quarter Earnings Result for 2020 |
10/30/2020 08:00 CDT | Misc | AbbVie Inc Third Quarter Earnings Conference Call for 2020 |
10/14/2020 | Dividends | Amount: 1.18, Declared Date: Sep 11 2020, Pay Date: Nov 16 2020 |
07/31/2020 08:00 CDT | Misc | AbbVie Inc Second Quarter Earnings Conference Call for 2020 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.abbvie.com
- Investor Relations URL: http://www.abbvieinvestor.com/phoenix.zhtml?c=251551&p=irol-IRHome
- HQ State/Province: Illinois
- Sector: Healthcare
- Industry: Drug Manufacturers - General
- Equity Style: Large Cap/Value
- Next Earnings Release: Apr. 30, 2021
- Last Earnings Release: Feb. 03, 2021
- Next Ex-Dividend Date: Apr. 14, 2021
- Last Ex-Dividend Date: Jan. 14, 2021
- Description: AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Analyst Coverage
Consensus Recommendations | |
Buy Recommendations | Upgrade |
Outperform Recommendations | Upgrade |
Hold Recommendations | Upgrade |
Underperform Recommendations | Upgrade |
Sell Recommendations | Upgrade |
Consensus Recommendation | Upgrade |
Consensus Rating | Upgrade |
Target Price | |
Price | 107.69 |
Price Target | Upgrade |
Price Target Upside (Daily) | Upgrade |
Top Fund Holders
Symbol | Name | Weighting |
---|---|---|
FIJYX | Fidelity Advisor® Biotechnology Z | 21.01% |
FBIOX | Fidelity® Select Biotechnology | 9.41% |
XLV | Health Care Select Sector SPDR® ETF | 4.44% |
VHT | Vanguard Health Care ETF | 3.35% |
QUAL | iShares MSCI USA Quality Factor ETF | 2.23% |
CIRFX | American Funds Capital Income Bldr 529F | 1.90% |
VHYAX | Vanguard High Dividend Yield Index Adm | 1.64% |
VYM | Vanguard High Dividend Yield ETF | 1.64% |
CMLFX | American Funds American Mutual 529F | 1.50% |
VTV | Vanguard Value ETF | 1.31% |
VIVAX | Vanguard Value Index Inv | 1.27% |
IWF | iShares Russell 1000 Growth ETF | 0.98% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ABBV Tweets Stocktwits
Advertisement